Minoxidil

Minoxidil
Systematic (IUPAC) name
3-hydroxy-2-imino-6-(1-piperidyl)pyrimidin-4-amine
Identifiers
CAS number	38304-91-5
ATC code	C02DC01 D11AX01
PubChem	4201
DrugBank	APRD00086
Chemical data
Formula	C9H15N5O
Mol. mass	209.251 g/mol
Pharmacokinetic data
Bioavailability	?
Metabolism	Primarily hepatic
Half life	4.2 hours
Excretion	renal
Therapeutic considerations
Pregnancy cat.	Additional recommended knowledge Daily Visual Balance Check How to ensure accurate weighing results every day? What is the Correct Way to Check Repeatability in Balances? C
Legal status	P(UK) for topical use, otherwise POM
Routes	Oral / topical

Minoxidil is a vasodilator and was exclusively used as an oral drug (Loniten®) to treat high blood pressure. It was, however, discovered to have the interesting side-effect of hair growth and reversing baldness, and in the 1980s, Upjohn Corporation produced a topical solution that contained 2% minoxidil to be used to treat baldness and hair loss, under the brand name Rogaine in the United States, and Regaine outside the United States. Treatments usually include a 5% concentration solutions that are designed for men, whereas the 2% concentration solutions are designed for women. It is unknown how the drug stimulates hair growth.

In 2007 a novel, foam-based formulation of 5% Minoxidil was shown to be an effective treatment of androgenetic alopecia without the usual side-effects of the topical solution. ^[1]

Minoxidil is a "potassium channel agonist." It contains the chemical structure of nitric oxide (NO), a blood vessel dilator, and may be a nitric oxide agonist. This may explain minoxidil's ability to stimulate hair growth and treat hair loss. Since minoxidil is a nitric oxide-related compound, it was suspected to act via activation of guanylate cyclase, an enzyme involved in vasodilation, however there are no reports of cGMP or PKG activation to date. ^[2]

Minoxidil is less effective when there is a large area of hair loss. In addition, its effectiveness has largely been demonstrated in younger men (18 to 41 years of age) and in those with balding in the central (vertex) portion of the scalp. ^[3]

The patent on minoxidil expired on February 13, 1996.^[4]

Side-effects

As a drug to combat hair loss, the most common side effect is itchy scalp. In some cases minoxidil may initially cause an increase in hair loss.

There have been cases of allergic reactions to minoxidil or the non-active ingredient propylene glycol, which is found in some forms of the topical version, such as Rogaine. Large amounts of minoxidil can cause hypotension, and it has been found that using petroleum jelly or tretinoin on the scalp with minoxidil can cause too much of the drug absorption by the scalp, as can using the drug on sunburned scalps.

If a person uses minoxidil to stop hair loss for a length of time and then stops taking the drug, hair loss will occur again.

Other side-effects include:

• acne on the area where it is being used as a topical solution
• headaches and/or lightheadedness
• very low blood pressure
• irregular or fast heart beat
• blurred vision
• chest pain

All the side-effects in the above list except for acne may be an indicator that too much of the drug is being used.

It has also been found that the drug can be passed from a mother to a child via breast milk.

See also

• Baldness treatments

References

• Minoxidil entry at healthatoz.com
• MEDLINEplus Drug Information: Minoxidil (Topical)

1. ^ Olsen EA, Whiting D, Bergfeld W, Miller J, Hordinsky M, Wanser R, Zhang P, Kohut B (2007). "A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men". J Am Acad Dermatol.. PMID 17761356.
2. ^ Alopecia & Free Radical "Redox" Signaling--Nitric Oxide and Superoxide. Retrieved on 2006-08-09.
3. ^ Medical Treatments for Balding in Men American Family PhysicianApril 15, 1999
4. ^ [1]